STRATEC SE · ISIN: DE000STRA555 · EQS - Company News

STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024

STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024 Measures to enhance earnings show effect; at 8.4%, adjusted EBIT margin for 9M/2024 almost matches previous year’s level (9M/2023: 8.6%) despite negative scale effects Sales on a constant-currency basis -6.0% to € 176.3 million in 9M/2024 (9M/2023: € 187.7 million) Significantly improved sales and earnings dynamics expected in fourth quarter of 2024 due to upcoming conclusion of additional orders 2024 guidance: Sales expected to remain s...

XETR:SBS Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News STRATEC SE

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (11)
Short Selling (DE) (2)
Short Selling (UK) (0)
25 October 2024 06:55AM
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024
DE000STRA555
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024 Measures to enhance earnings show effect; at 8.4%, adjusted EBIT margin for 9M/2024 almost matches previous year’s level (9M/2023: 8.6%) despite negative scale effects Sales on a constant-currency basis -6.0% to € 176.3 million in 9M/2024 (9M/2023: € 187.7 million) Significantly improved sal...
STRATEC SE
About the publication
17 October 2024 07:43PM
TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN CONFIRMED WITH ADJUSTMENT TO 2024 SALES GUIDANCE
DE000STRA555
STRATEC POSTS PRELIMINARY RESULTS FOR FIRST NINE MONTHS OF 2024; TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN CONFIRMED WITH ADJUSTMENT TO 2024 SALES GUIDANCE Birkenfeld, October 17, 2024 Based on preliminary figures, STRATEC generated consolidated sales of € 176.3 million in the first nine months of 2024 (9M/2023: € 187.7 million). Its sales perform...
STRATEC SE
About the publication
09 August 2024 06:55AM
STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
DE000STRA555
STRATEC POSTS RESULTS FOR FIRST HALF OF 2024 Considerably improved business dynamics in second quarter (sales Q2/2024: constant currency +5.3%); sales in H1/2024: constant currency -4.9% to € 119.1 million (H1/2023: € 125.0 million) Adjusted EBIT margin of 9.6% in Q2/2024 (Q2/2023: 4.9%); adjusted EBIT margin in H1/2024 improves by 260 basis poi...
STRATEC SE
About the publication
30 July 2024 09:55AM
STRATEC REPORTS CHANGES IN FINANCE DIVISION
DE000STRA555
STRATEC REPORTS CHANGES IN FINANCE DIVISION Birkenfeld, July 30, 2024 STRATEC SE, a leading manufacturer of automation solutions for partners in clinical diagnostics and life sciences, is reporting a change in the composition of its Board of Management. In agreement with the company, Dr. Robert Siegle, a member of the Board of Management of STR...
STRATEC SE
About the publication
17 May 2024 05:33PM
STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS
DE000STRA555
STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS Birkenfeld, May 17, 2024 Shareholders at today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX) approved all agenda items submitted for resolution with the necessary majority in each case. As proposed, STRATEC will enable its ...
STRATEC SE
About the publication
26 April 2024 06:55AM
STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024
DE000STRA555
STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 Subdued start to financial year as expected, but noticeable revival apparent in market and very strong sales growth expected for second quarter of 2024 Consolidated sales Q1/2024 -15.7% at constant currency to € 50.9 million (Q1/2023: € 60.5 million) Efficiency measures and structural changes taki...
STRATEC SE
About the publication
28 March 2024 06:55AM
STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
DE000STRA555
STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 gu...
STRATEC SE
About the publication
28 March 2024 06:55AM
STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
DE000STRA555
STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 gu...
STRATEC SE
About the publication
21 March 2024 02:52PM
STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
DE000STRA555
STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR Birkenfeld, March 21, 2024 The Supervisory Board and Board of Management of STRATEC plan to propose the distribution of a dividend of € 0.55 per share for the 2023 financial year for approval by the Annual General Meeting on May 17, 2024 (previous year: € 0.97 per sh...
STRATEC SE
About the publication
21 December 2023 04:59PM
STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
DE000STRA555
STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, December 21, 2023 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at the Westin St. Francis in San Francisco, CA, USA. Marcus Wolfinge...
STRATEC SE
About the publication
27 October 2023 06:55AM
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
DE000STRA555
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023 Significant intra-year improvement in profitability in third quarter of 2023 (adjusted EBIT margin of 14.8% in Q3/2023); adjusted EBIT margin of 8.6% in 9M/2023 (9M/2022: 18.3%) Sales performance still adversely affected by excess molecular diagnostics capacities built up during pandemic; con...
STRATEC SE
About the publication
09 August 2023 06:55AM
STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023
DE000STRA555
STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023 Consolidated sales in H1/2023 -8.9% to € 125.0 million (H1/2022: € 137.2 million); +4.4% in Q2/2023 Adjusted EBIT margin at 5.6% (H1/2022: 15.4%) Further market launches for customers and strong development pipeline underpin positive medium to long-term growth prospects North America business ...
STRATEC SE
About the publication
18 July 2023 08:11PM
STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR
DE000STRA555
STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR Birkenfeld, July 18, 2023 Based on preliminary figures, STRATEC generated sales of € 125.0 million in the first half of 2023 (H1/2022: € 137.2 million). This marks a reduction of 8.9% (constant currency: -9.1%) compared with the previous year. The adjust...
STRATEC SE
About the publication
18 July 2023 08:11PM
STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR
DE000STRA555
STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR Birkenfeld, July 18, 2023 Based on preliminary figures, STRATEC generated sales of € 125.0 million in the first half of 2023 (H1/2022: € 137.2 million). This marks a reduction of 8.9% (constant currency: -9.1%) compared with the previous year. The adjust...
STRATEC SE
About the publication
04 July 2023 12:13PM
STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS
DE000STRA555
STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS Birkenfeld, July 4, 2023 STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, SDAX) can today announce the successful completion of the acquisition of Natech Plastics, Inc. (hereinafter: “Natech”), based in Ronkonkoma, NY/USA as of July 1, 2023. This follows on the agreement to fully ac...
STRATEC SE
About the publication
04 July 2023 12:13PM
STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS
DE000STRA555
STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS Birkenfeld, July 4, 2023 STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, SDAX) can today announce the successful completion of the acquisition of Natech Plastics, Inc. (hereinafter: “Natech”), based in Ronkonkoma, NY/USA as of July 1, 2023. This follows on the agreement to fully ac...
STRATEC SE
About the publication
07 June 2023 07:00AM
STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS
DE000STRA555
STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS  Acquisition of smart polymer-based consumables provider focused on medical applications The addition of a local production site will extend STRATEC’s focus on the US market Diversification due to high share of recurring sales, extended customer base, and complementary tar...
STRATEC SE
About the publication
07 June 2023 07:00AM
STRATEC SE: STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS
DE000STRA555
STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS  Acquisition of smart polymer-based consumables provider focused on medical applications The addition of a local production site will extend STRATEC’s focus on the US market Diversification due to high share of recurring sales, extended customer base, and complementary tar...
STRATEC SE
About the publication
17 May 2023 04:31PM
STRATEC’S ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO € 0.97 PER SHARE
DE000STRA555
STRATEC’S ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO € 0.97 PER SHARE Birkenfeld, May 17, 2023 Shareholders at today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX) approved all agenda items submitted for resolution with clear majorities. As in the past three years, the Annual G...
STRATEC SE
About the publication
17 May 2023 04:31PM
DISTRIBUTION RISES TO € 0.97 PER SHARE
DE000STRA555
STRATEC’S ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO € 0.97 PER SHARE Birkenfeld, May 17, 2023 Shareholders at today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX) approved all agenda items submitted for resolution with clear majorities. As in the past three years, the Annual G...
STRATEC SE
About the publication
28 April 2023 06:55AM
STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE
DE000STRA555
STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE Sales in Q1/2023 -19.8% to € 60.5 million; constant-currency -20.7% (Q1/2022: € 75.4 million) Adjusted EBIT margin of 6.3% in Q1/2023 as expected below previous year (Q1/2022: 19.9%) 2023 guidance confirmed: Constant-currency sales growth of 8.0% to 12.0% and adjuste...
STRATEC SE
About the publication
28 April 2023 06:55AM
STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE
DE000STRA555
STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE Sales in Q1/2023 -19.8% to € 60.5 million; constant-currency -20.7% (Q1/2022: € 75.4 million) Adjusted EBIT margin of 6.3% in Q1/2023 as expected below previous year (Q1/2022: 19.9%) 2023 guidance confirmed: Constant-currency sales growth of 8.0% to 12.0% and adjuste...
STRATEC SE
About the publication
30 March 2023 06:55AM
STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR
DE000STRA555
STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR Consolidated sales in 2022 -4.4% to € 274.6 million (2021: € 287.3 million); constant-currency: -8.3% Adjusted EBIT margin of 16.4% (2021: 18.9%) broadly in line with original expectations Major product launch for one of the market leaders in molecular diagnostics and a well-stocked develo...
STRATEC SE
About the publication
30 March 2023 06:55AM
STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR
DE000STRA555
STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR Consolidated sales in 2022 -4.4% to € 274.6 million (2021: € 287.3 million); constant-currency: -8.3% Adjusted EBIT margin of 16.4% (2021: 18.9%) broadly in line with original expectations Major product launch for one of the market leaders in molecular diagnostics and a well-stocked develo...
STRATEC SE
About the publication
09 March 2023 08:08PM
STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
DE000STRA555
STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023 Birkenfeld, March 9, 2023 Based on preliminary figures, STRATEC expects to report consolidated sales of € 274.6 million for the 2022 financial year (2021: € 287.3 million). This corresponds to a year-on-year reduction in sales by 4.4% (constant curr...
STRATEC SE
About the publication
09 March 2023 08:08PM
STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
DE000STRA555
STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023 Birkenfeld, March 9, 2023 Based on preliminary figures, STRATEC expects to report consolidated sales of € 274.6 million for the 2022 financial year (2021: € 287.3 million). This corresponds to a year-on-year reduction in sales by 4.4% (constant curr...
STRATEC SE
About the publication
15 December 2022 03:34PM
STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
DE000STRA555
STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, December 15, 2022 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at the Westin St. Francis in San Francisco, CA, USA. Marcus Wolfing...
STRATEC SE
About the publication
15 December 2022 03:34PM
STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
DE000STRA555
STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, December 15, 2022 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at the Westin St. Francis in San Francisco, CA, USA. Marcus Wolfing...
STRATEC SE
About the publication
01 December 2022 04:14PM
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE
DE000STRA555
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE Birkenfeld, December 1, 2022 The Supervisory Board of STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) has decided to extend the company’s Board of Management with a further member and appointed Dr. Georg Bauer to the Board with responsibility for sales as of January 1, ...
STRATEC SE
About the publication
01 December 2022 04:14PM
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE
DE000STRA555
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE Birkenfeld, December 1, 2022 The Supervisory Board of STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) has decided to extend the company’s Board of Management with a further member and appointed Dr. Georg Bauer to the Board with responsibility for sales as of January 1, ...
STRATEC SE
About the publication
03 November 2022 06:55AM
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
DE000STRA555
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022 Sales in 9M/2022 -7.9% to € 207.7 million (9M/2021: € 225.4 million); constant currency: -11.7% Adjusted EBIT of € 38.1 million in 9M/2022 (9M/2021: € 48.7 million) Adjusted EBIT margin of 18.3% (9M/2021: 21.6%) at upper end of target corridor communicated for full year Significant product ...
STRATEC SE
About the publication
03 November 2022 06:55AM
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
DE000STRA555
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022 Sales in 9M/2022 -7.9% to € 207.7 million (9M/2021: € 225.4 million); constant currency: -11.7% Adjusted EBIT of € 38.1 million in 9M/2022 (9M/2021: € 48.7 million) Adjusted EBIT margin of 18.3% (9M/2021: 21.6%) at upper end of target corridor communicated for full year Significant product ...
STRATEC SE
About the publication
18 October 2022 08:24PM
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
DE000STRA555
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE Birkenfeld, October 18, 2022 Based on preliminary figures, STRATEC expects to report consolidated sales of € 207.7 million for the first nine months of 2022 (9M/2021: € 225.4 million). This corresponds to a year-on-year reduction in sales by 7.9% (constan...
STRATEC SE
About the publication
18 October 2022 08:24PM
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
DE000STRA555
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE Birkenfeld, October 18, 2022 Based on preliminary figures, STRATEC expects to report consolidated sales of € 207.7 million for the first nine months of 2022 (9M/2021: € 225.4 million). This corresponds to a year-on-year reduction in sales by 7.9% (constan...
STRATEC SE
About the publication
10 August 2022 06:55AM
STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DE000STRA555
STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE Sales in H1/2022 -11.9% to € 137.2 million (H1/2021: € 155.8 million); constant currency: -15.2% Adjusted EBIT of € 21.2 million in H1/2022 (H1/2021: € 34.5 million) Adjusted EBIT margin of 15.4% (H1/2021: 22.1%) Preparations for serial production are advancing succe...
STRATEC SE
About the publication
10 August 2022 06:55AM
STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DE000STRA555
STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE Sales in H1/2022 -11.9% to € 137.2 million (H1/2021: € 155.8 million); constant currency: -15.2% Adjusted EBIT of € 21.2 million in H1/2022 (H1/2021: € 34.5 million) Adjusted EBIT margin of 15.4% (H1/2021: 22.1%) Preparations for serial production are advancing succe...
STRATEC SE
About the publication
25 July 2022 06:21PM
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DE000STRA555
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE Birkenfeld, July 25, 2022 Based on preliminary figures, STRATEC expects to report consolidated sales of € 137.2 million for the first half of 2022 (H1/2021: € 155.8 million). This corresponds to a year-on-year reduction in sales by 11.9% (constant currency:...
STRATEC SE
About the publication
25 July 2022 06:21PM
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DE000STRA555
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE Birkenfeld, July 25, 2022 Based on preliminary figures, STRATEC expects to report consolidated sales of € 137.2 million for the first half of 2022 (H1/2021: € 155.8 million). This corresponds to a year-on-year reduction in sales by 11.9% (constant currency:...
STRATEC SE
About the publication
20 May 2022 05:10PM
STRATEC’S ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARD
DE000STRA555
STRATEC’S ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARD Birkenfeld, May 20, 2022 At today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX), the company’s shareholders approved all agenda items submitted for resolution with clear majorities. As in the past two years, the Annual Ge...
STRATEC SE
About the publication
05 May 2022 06:55AM
STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022
DE000STRA555
STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022 - Sales rise by 4.7% to € 75.4 million in Q1/2022; +1.8% at constant-currency (Q1/2021: € 72.0 million) - At € 15.0 million, adjusted EBIT for Q1/2022 only moderately below previous year’s high pandemic-related basis of comparison (Q1/2021: € 16.0 million) - Adjuste...
STRATEC SE
About the publication
30 March 2022 06:55AM
STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR
DE000STRA555
STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR - Consolidated sales at constant currency up by 16.7% to € 287.3 million in 2021; nominal +14.9% (2020: € 250.1 million) - Adjusted EBIT for 2021 increases by 30.1% to € 54.3 million (2020: € 41.7 million) - Adjusted EBIT margin improves by 220 basis points to 18.9% (2020: 16....
STRATEC SE
About the publication
11 November 2021 06:50AM
STRATEC POSTS SUBSTANTIAL GROWTH AND INCREASED PROFITABILITY IN FIRST NINE MONTHS OF 2021
DE000STRA555
STRATEC POSTS SUBSTANTIAL GROWTH AND INCREASED PROFITABILITY IN FIRST NINE MONTHS OF 2021 - Sales in 9M/2021 increase by 29.5% at constant-currency to € 225.4 million (9M/2020: € 179.1 million); nominal 25.9% - Adjusted EBIT in 9M/2021 rises by 73.1% to € 48.7 million (9M/2020: € 28.1 million) - Adjusted EBIT margin improves by 590 basis points to...
STRATEC SE
About the publication
03 November 2021 02:00PM
STRATEC SE: DR. RUDOLF EUGSTER AS NEW CHAIR OF SUPERVISORY BOARD / PLANNED INCREASE IN NUMBER OF SUPERVISORY BOARD MEMBERS
DE000STRA555
STRATEC SE: DR. RUDOLF EUGSTER AS NEW CHAIR OF SUPERVISORY BOARD / PLANNED INCREASE IN NUMBER OF SUPERVISORY BOARD MEMBERS Birkenfeld, November 3, 2021 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) can today announce that Dr. Rudolf Eugster has been appointed by Mannheim District Court to be a member of the Supervisory B...
STRATEC SE
About the publication
28 October 2021 02:57PM
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2021 AND RAISES FINANCIAL GUIDANCE
DE000STRA555
STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2021 AND RAISES FINANCIAL GUIDANCE Birkenfeld, October 28, 2021 Based on preliminary figures, STRATEC can report further record sales and earnings for the first nine months of 2021. According to these figures, STRATEC expects consolidated sales of € 225.4 million for the first nine mont...
STRATEC SE
About the publication
06 August 2021 07:00AM
STRATEC POSTS NEW RECORD LEVEL OF SALES AND EARNINGS IN FIRST HALF OF 2021
DE000STRA555
STRATEC POSTS NEW RECORD LEVEL OF SALES AND EARNINGS IN FIRST HALF OF 2021 - Sales up by 36.0% at constant currency to € 155.8 million in H1/2021; nominal +30.5% (H1/2020: € 119.4 million) - Adjusted EBIT in H1/2021 rises by 87.1% to € 34.5 million (H1/2020: € 18.4 million) - Adjusted EBIT margin improves by 670 base points to 22.1% (H1/2020: 1...
STRATEC SE
About the publication
21 July 2021 05:56PM
STRATEC POSTS PRELIMINARY FIGURES FOR THE FIRST HALF AND PUBLISHES NEW SALES GUIDANCE FOR THE 2021 FINANCIAL YEAR
DE000STRA555
STRATEC POSTS PRELIMINARY FIGURES FOR THE FIRST HALF AND PUBLISHES NEW SALES GUIDANCE FOR THE 2021 FINANCIAL YEAR Birkenfeld, July 21, 2021 Based on preliminary figures, STRATEC expects to report consolidated sales of € 155.8 million for the first half of 2021 (previous year: € 119.4 million), corresponding to constant-currency sales growth of 36....
STRATEC SE
About the publication
20 May 2021 03:50PM
STRATEC'S ANNUAL GENERAL MEETING APPROVES SEVENTEENTH CONSECUTIVE DIVIDEND INCREASE
DE000STRA555
STRATEC'S ANNUAL GENERAL MEETING APPROVES SEVENTEENTH CONSECUTIVE DIVIDEND INCREASE Birkenfeld, May 20, 2021 At today's Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX), which was held on a virtual basis due to the current situation, the company's shareholders approved all agenda items submitted for resolution with cle...
STRATEC SE
About the publication
07 May 2021 06:55AM
STRATEC WITH FURTHER ACCELERATION IN SALES AND EARNINGS GROWTH IN FIRST QUARTER OF 2021
DE000STRA555
STRATEC WITH FURTHER ACCELERATION IN SALES AND EARNINGS GROWTH IN FIRST QUARTER OF 2021 - Sales up by 32.5% at constant currency to € 72.0 million in Q1/2021; nominal +27.4%   (Q1/2020: € 56.5 million) - Adjusted EBIT in Q1/2021 rises by 109.5% to € 16.0 million (Q1/2020: € 7.7 million) - Adjusted EBIT margin for Q1/2021 improves by 870 basis po...
STRATEC SE
About the publication
More STRATEC SE related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 11 17th March 2023 Wolfinger, Marcus DD
Short Seller (DE) 2 22nd February 2023 Millennium International Management LP SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN